# A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid Arthritis

> **NCT01382940** · PHASE4 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 351 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** rituximab
- **DRUG:** methotrexate
- **DRUG:** methylprednisolone
- **DRUG:** acetaminophen
- **DRUG:** antihistamine

## Key facts

- **NCT ID:** NCT01382940
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07-26
- **Primary completion:** 2013-01-06
- **Final completion:** 2013-01-06
- **Target enrollment:** 351 (ACTUAL)
- **Last updated:** 2017-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01382940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01382940, "A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01382940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*